Login / Signup

Sirolimus as a second-line treatment for Graves' orbitopathy.

G LanzollaM N MaglionicoS ComiF MenconiP PiaggiC PosarelliM FigusC MarcocciMichele Marinò
Published in: Journal of endocrinological investigation (2022)
Sirolimus seems to be an effective second-line treatment for GO. Further randomized clinical trials are needed to confirm our observations.
Keyphrases
  • clinical trial
  • replacement therapy
  • smoking cessation